News about Market

FDA Proposes New Rule on Reporting RequirementUnder Right to Try Act

FDA Proposes New Rule on Reporting RequirementUnder Right to Try Act

Today, the U.S. Food and Drug Administration published the proposed rule, Annual Summary Reporting Requirements Under the Right to Try Act, that when finalized, will implement a statutory requirement for sponsors and manufacturers to provide annual summary to the FDA for any eligible investigational drug they provide to eligible patients under Try Act

Market | 27/07/2020 | By Darshana

FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology

Market | 11/06/2020 | By Darshana 133

Dr. Reddy's Labs completes acquisition of select business divisions of Wockhardt

Dr. Reddy's Labs completes acquisition of select business divisions of Wockhardt

Dr. Reddy's Laboratories Ltd announced that it has completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives

Market | 10/06/2020 | By Darshana

Federal Government Announces New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online

Federal Government Announces New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online

The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online

Market | 09/06/2020 | By Darshana

Merck enters collaboration with Ridgeback Bio to develop antiviral candidate, EIDD-2801 to treat COVID-19

Merck enters collaboration with Ridgeback Bio to develop antiviral candidate, EIDD-2801 to treat COVID-19

Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical development for the treatment of patients with COVID-19

Market | 28/05/2020 | By Darshana

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Roche today announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche?s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX?).

Market | 22/05/2020 | By Darshana

Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Dr Lal PathLabs Q4 net profit dips 31% to Rs. 32.6 crore

Dr Lal PathLabs Limited, a leading diagnostic and related healthcare service provider posted 31% dip in net profit at Rs. 32.6 crore for the fourth quarter ended March 31, 2020 as compared to Rs. 47.4 crore in Q4 last year

Market | 19/05/2020 | By Darshana

New data at the ASCO20 Virtual Scientific Program reflects Roche?s commitment to accelerating progress in cancer care

New data at the ASCO20 Virtual Scientific Program reflects Roche?s commitment to accelerating progress in cancer care

Roche today announced that new data from clinical trials of 19 approved and investigational medicines across 21 cancer types, will be presented at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO), which will be held 29-31 May, 2020

Market | 08/05/2020 | By Darshana

IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19

IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19

Indian Institute of Technology Guwahati is collaborating with Hester Biosciences Limited, a pharmaceutical company based in Ahmedabad, Gujarat, to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020

Market | 29/04/2020 | By Darshana

Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals

Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals

Syngene International Ltd., a global research and development services company, today announced the opening of a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management

Market | 28/04/2020 | By Darshana

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology